Trial Profile

First in-human study of AMG 853 in healthy subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 05 Nov 2010

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs AMG-853 (Primary)
Indications Asthma
Focus Adverse reactions; Pharmacokinetics
Sponsors Amgen

Most Recent Events

05 Nov 2010 New trial record.
14 May 2010 Results presented at the 106th International Conference of the American Thoracic Society.
26 Feb 2010 Results presented at the 66th Annual Meeting of the American Academy of Allergy, Asthma and Immunology.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com